Does MOGAMULIZUMAB Cause Nasopharyngitis? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Nasopharyngitis have been filed in association with MOGAMULIZUMAB (POTELIGEO). This represents 1.8% of all adverse event reports for MOGAMULIZUMAB.
8
Reports of Nasopharyngitis with MOGAMULIZUMAB
1.8%
of all MOGAMULIZUMAB reports
3
Deaths
2
Hospitalizations
How Dangerous Is Nasopharyngitis From MOGAMULIZUMAB?
Of the 8 reports, 3 (37.5%) resulted in death, 2 (25.0%) required hospitalization, and 2 (25.0%) were considered life-threatening.
Is Nasopharyngitis Listed in the Official Label?
Yes, Nasopharyngitis is listed as a known adverse reaction in the official FDA drug label for MOGAMULIZUMAB.
What Other Side Effects Does MOGAMULIZUMAB Cause?
Rash (59)
Disease progression (46)
Infusion related reaction (42)
Pyrexia (35)
Febrile neutropenia (29)
Erythema (28)
Pruritus (26)
Drug ineffective (24)
Constipation (22)
Death (21)
What Other Drugs Cause Nasopharyngitis?
ADALIMUMAB (13,753)
ETANERCEPT (12,421)
METHOTREXATE (8,046)
TOFACITINIB (7,781)
SECUKINUMAB (7,022)
TOCILIZUMAB (6,664)
RITUXIMAB (6,321)
ABATACEPT (6,143)
INFLIXIMAB (5,353)
CERTOLIZUMAB PEGOL (5,295)
Which MOGAMULIZUMAB Alternatives Have Lower Nasopharyngitis Risk?
MOGAMULIZUMAB vs MOGAMULIZUMAB-KPKC
MOGAMULIZUMAB vs MOLNUPIRAVIR
MOGAMULIZUMAB vs MOLSIDOMINE
MOGAMULIZUMAB vs MOMELOTINIB
MOGAMULIZUMAB vs MOMETASONE